SH2B3 alterations in a novel genetic condition, juvenile myelomonocytic leukemia, and myeloproliferative neoplasia

Haematologica. 2024 Aug 1;109(8):2391-2394. doi: 10.3324/haematol.2023.284747.

Authors

Charlotte M Niemeyer¹, Miriam Erlacher²

Affiliations

¹ Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg. charlotte.niemeyer@uniklinik-freiburg.de.
² Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adaptor Proteins, Signal Transducing* / genetics
Female
Humans
Intracellular Signaling Peptides and Proteins / genetics
Leukemia, Myelomonocytic, Juvenile* / diagnosis
Leukemia, Myelomonocytic, Juvenile* / genetics
Leukemia, Myelomonocytic, Juvenile* / pathology
Male
Mutation*
Myeloproliferative Disorders* / diagnosis
Myeloproliferative Disorders* / genetics

Substances

SH2B3 protein, human
Adaptor Proteins, Signal Transducing
Intracellular Signaling Peptides and Proteins